195 related articles for article (PubMed ID: 21865390)
1. Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.
Wang Z; Ni J; Li J; Shi B; Xu Y; Yuan Z
J Virol; 2011 Nov; 85(21):11457-67. PubMed ID: 21865390
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
[TBL] [Abstract][Full Text] [Related]
3. RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.
Mao R; Dong M; Shen Z; Zhang H; Liu Y; Cai D; Mitra B; Zhang J; Guo H
J Virol; 2021 Sep; 95(19):e0044421. PubMed ID: 34287051
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
[TBL] [Abstract][Full Text] [Related]
5. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
Ma C; Xu W; Yang Q; Liu W; Xiang Q; Chen J; Zhang Q; Liu Y; Wu K; Wu J
J Virol; 2020 May; 94(11):. PubMed ID: 32188736
[TBL] [Abstract][Full Text] [Related]
6. The E3 Ubiquitin Ligase TRIM21 Promotes HBV DNA Polymerase Degradation.
Mu T; Zhao X; Zhu Y; Fan H; Tang H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32245233
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
[TBL] [Abstract][Full Text] [Related]
8. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors.
Zhang P; Liu F; Guo F; Zhao Q; Chang J; Guo JT
Antiviral Res; 2016 Jul; 131():40-8. PubMed ID: 27083116
[TBL] [Abstract][Full Text] [Related]
9. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.
Mao R; Nie H; Cai D; Zhang J; Liu H; Yan R; Cuconati A; Block TM; Guo JT; Guo H
PLoS Pathog; 2013; 9(7):e1003494. PubMed ID: 23853601
[TBL] [Abstract][Full Text] [Related]
11. RNA-Binding Motif Protein 24 (RBM24) Is Involved in Pregenomic RNA Packaging by Mediating Interaction between Hepatitis B Virus Polymerase and the Epsilon Element.
Yao Y; Yang B; Chen Y; Wang H; Hu X; Zhou Y; Gao X; Lu M; Niu J; Wen Z; Wu C; Chen X
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626666
[TBL] [Abstract][Full Text] [Related]
12. Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidation.
Cao F; Jones S; Li W; Cheng X; Hu Y; Hu J; Tavis JE
J Viral Hepat; 2014 Dec; 21(12):882-93. PubMed ID: 24401091
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs.
Li J; Lin S; Chen Q; Peng L; Zhai J; Liu Y; Yuan Z
J Virol; 2010 Jul; 84(13):6387-99. PubMed ID: 20410269
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA.
Jeong JK; Yoon GS; Ryu WS
J Virol; 2000 Jun; 74(12):5502-8. PubMed ID: 10823855
[TBL] [Abstract][Full Text] [Related]
15. The interaction of hepatitis B virus with the ubiquitin proteasome system in viral replication and associated pathogenesis.
Kong F; You H; Kong D; Zheng K; Tang R
Virol J; 2019 May; 16(1):73. PubMed ID: 31146743
[TBL] [Abstract][Full Text] [Related]
16. cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.
Lau R; Niu MY; Pratt MA
Cell Cycle; 2012 Nov; 11(21):4009-19. PubMed ID: 23032264
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.
Jiménez-Lara AM; Aranda A; Gronemeyer H
Mol Cancer; 2010 Jan; 9():15. PubMed ID: 20102612
[TBL] [Abstract][Full Text] [Related]
18. TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein.
Nakaya Y; Nishizawa T; Nishitsuji H; Morita H; Yamagata T; Onomura D; Murata K
Sci Rep; 2023 Aug; 13(1):13584. PubMed ID: 37604854
[TBL] [Abstract][Full Text] [Related]
19. 3,7-Dihydroxytropolones Inhibit Initiation of Hepatitis B Virus Minus-Strand DNA Synthesis.
Bak E; Miller JT; Noronha A; Tavis J; Gallicchio E; Murelli RP; Le Grice SFJ
Molecules; 2020 Sep; 25(19):. PubMed ID: 32992516
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus replication and release are independent of core lysine ubiquitination.
Garcia ML; Byfield R; Robek MD
J Virol; 2009 May; 83(10):4923-33. PubMed ID: 19244316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
